References
- Sherlock S: Diseases of the Liver and Biliary System. Ed 4. Philadelphia, FA Davis Co. 1968
- Baron DN: A critical look at the value of biochemical liver function tests with special reference to discriminant function analysis. Ann Clin Biochem 7:100, 1970
- Skrede S, Blomhoff JP, Elgio K. et al: Biochemical tests in evaluation of liver function. Scand J Gastroenterol (Suppl) 19:37–46, 1973
- Lum G, Gambino SR: Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas or bone. Clin Chem 18:358–362, 1972
- Burke MD: Liver function. Hum Pathol 6:273–286, 1975
- Burke MD: Clinical enzymology: 2. Test strategies and interpretation of results. Postgrad Med 64:149–156, Aug 1978
- Bailey A, Robinson D, Dawson AM: Does Gilbert's disease exist? Lancet 1:931–933, 1977
- Sherlock S, Scheuer PJ: The presentation and diagnosis of 100 patients with primary cirrhosis. N Engl J Med 289:674–678, 1973
- Sherlock S: Predicting progression of acute type-B hepatitis to chronicity. Lancet 2:354–356, 1976
- Chronic hepatitis. (Editorial) Br Med J 2:1171, 1977
- Alpert E: Alpha-l-fetoprotein. Clin Gastroenterol 5:639–644, 1976
- Hansen HJ, Snyder JJ, Miller E, et al: Carcinoembryonic antigen (CEA) assay: A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol 5:139–147, 1974
- Sugarbaker PH, Beard JO, Drug DE: Detection of hepatic metastases from cancer of the breast. Am J Surg 133:531–535, 1977
- Mackay AM, Patel S, Carter S, et al: Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J 4:382–385, 1974